Linked Data API

Show Search Form

Search Results

429087
registered interest false more like this
date less than 2015-11-18more like thismore than 2015-11-18
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Department of Health: Lobbying more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will assess the extent to which grants made by his Department to third parties are used for activities designed to influence his Department, other departments or Parliament. more like this
tabling member constituency Romford more like this
tabling member printed
Andrew Rosindell remove filter
uin 16779 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-11-23more like thismore than 2015-11-23
answer text <p>Funding applications from voluntary sector organisations are assessed against a number of criteria, but Departmental policy clearly states that grants will not be awarded if there is any indication within the application that some or all of any funding awarded will be used to support political activities, including political lobbying activity.</p><br /><p>It remains an important objective of the Department’s partnership with the voluntary, community and social enterprise sector that they contribute their voice and expertise to national policy making and implementation, and grant awards can support this objective.</p><br /><p>However, analysis of each individual grant awarded by the Department to ascertain the impact of this objective would be at disproportionate cost.</p><br /> more like this
answering member constituency North East Bedfordshire more like this
answering member printed Alistair Burt more like this
grouped question UIN 16835 more like this
question first answered
remove maximum value filtermore like thismore than 2015-11-23T15:53:41.103Z
answering member
1201
label Biography information for Alistair Burt more like this
tabling member
1447
label Biography information for Andrew Rosindell more like this
423894
registered interest false more like this
date less than 2015-10-26more like thismore than 2015-10-26
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading MRSA more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will make a comparative assessment of the number of recorded MRSA infections in (a) Havering and (b) other districts in (i) the present and (ii) the last three years; and if he will make a statement. more like this
tabling member constituency Romford more like this
tabling member printed
Andrew Rosindell remove filter
uin 13412 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-11-03more like thismore than 2015-11-03
answer text <p>Public Health England (PHE) is unable to provide the number of recorded Methicillin Resistant <em>Staphylococcus Aureus</em> (MRSA) infections by borough/district.</p><br /><p>PHE is able to provide this information by clinical commissioning groups (CCGs) and acute trusts.</p><br /><p>Table 1 details counts/rates of total MRSA bacteraemia reported by Havering, Barking and Redbridge University hospitals trust and Table 2 lists counts/rates of MRSA bacteraemia attributed to Havering CCG over the last three financial years.</p><br /><p>It is important to note that MRSA bacteraemia cases are reported by the acute trust whose laboratory processes the specimen and that this may not always reflect where the bacteraemia was acquired. Counts/rates for total MRSA bacteraemia reported in other CCGs and acute trusts in England is attached and can be found on the gov.uk website:</p><br /><p><a href="https://www.gov.uk/government/statistics/mrsa-bacteraemia-annual-data" target="_blank">https://www.gov.uk/government/statistics/mrsa-bacteraemia-annual-data</a></p><br /><p>PHE is working, with partner organisations, to address antimicrobial resistance through the implementation of the ‘UK Five Year Antimicrobial Resistance Strategy’<sup>1</sup>.</p><br /><p><strong><br> </strong></p><br /> <br /> <br /><p>Table 1: Financial year counts and rates of total MRSA bacteraemia reported by Havering, Barking &amp; Redbridge University hospitals (FY 2012/13 to FY 2014/15)</p><br /><table><tbody><tr><td><p><br></p></td><td colspan="2"><p>FY 2012/13</p></td><td colspan="2"><p>FY 2013/14</p></td><td colspan="2"><p>FY 2014/15</p></td></tr><tr><td><p>Trust Code</p></td><td><p>Trust Name</p></td><td><p>MRSA bacteraemia reports</p></td><td><p>MRSA bacteraemia rate per 100,000 bed days</p></td><td><p>MRSA bacteraemia reports</p></td><td><p>MRSA bacteraemia rate per 100,000 bed days</p></td><td><p>MRSA bacteraemia reports</p></td><td><p>MRSA bacteraemia rate per 100,000 bed days</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p><br></p></td><td><p>England Total</p></td><td><p>924</p></td><td><p>2.7</p></td><td><p>862</p></td><td><p>2.5</p></td><td><p>801</p></td><td><p>2.3</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p>RF4</p></td><td><p>Barking, Havering and Redbridge University Hospitals</p></td><td><p>17</p></td><td><p>4.7</p></td><td><p>10</p></td><td><p>2.9</p></td><td><p>13</p></td><td><p>3.7</p></td></tr></tbody></table><br /> <br /><p><em>Source:</em> PHE July 2015 annual publication of surveillance data</p><br /><p><em>Notes:</em></p><p>Bed days were calculated using KH03 data for the stated period. The average daily bed occupancy for the Trust quoted has been multiplied by the number of days in the time period. Rate per 100,000 bed days is calculated as follows<strong>:</strong></p><p>Calculation of rate (per 100,000 bed days) = [Number of MRSA bacteraemia reports from the trust for the time period divided by Average daily bed occupancy multiplied by Number of days in the time period] multiplied by 100,000</p><br /> <br /><p>NB: Included KH03 data are as of April 2015. KH03 data for January to March 2015 were not available at this time. Data for the same quarter last year (January to March 2014) has been used in FY 2014/15 bed day calculation.</p><br /> <br /><p>Table 2: Financial year counts and rates of MRSA bacteraemia attributed to Havering CCG (FY 2012/13 to FY 2014/15)</p><br /><table><tbody><tr><td><p><br></p></td><td><p><br></p></td><td colspan="2"><p>FY 2012/13</p></td><td colspan="2"><p>FY 2013/14</p></td><td colspan="2"><p>FY 2014/15</p></td></tr><tr><td><p>CCG Code</p></td><td><p>CCG Name</p></td><td><p>Total attributed MRSA bacteraemia specimens</p></td><td><p>MRSA bacteraemia rate per 100,000 population</p></td><td><p>Total attributed MRSA bacteraemia specimens</p></td><td><p>MRSA bacteraemia rate per 100,000 population</p></td><td><p>Total attributed MRSA bacteraemia specimens</p></td><td><p>MRSA bacteraemia rate per 100,000 population</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p><br></p></td><td><p>England Total</p></td><td><p>924</p></td><td><p>1.7</p></td><td><p>862</p></td><td><p>1.6</p></td><td><p>801</p></td><td><p>1.5</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p>08F</p></td><td><p>Havering</p></td><td><p>9</p></td><td><p>3.8</p></td><td><p>6</p></td><td><p>2.5</p></td><td><p>6</p></td><td><p>2.5</p></td></tr></tbody></table><br /> <br /><p>Source: PHE July 2015 annual publication of surveillance data</p><br /><p><em>Notes:</em> CCG Populations are based upon Office for National Statistics (ONS) Mid-Year Population Estimates (2011 Census based). The relevant rate per 100,000 population was calculated as follows:</p><br /><p>Calculation of rate (per 100,000 bed days) = [Number of MRSA bacteraemia reports from that CCG for the given time period divided by CCG level population estimate] multiplied by 100,000</p><br /><p>NB: Included population data are as of April 2015. 2014 population estimates were not available at this time. 2013 population estimate data has been used as a proxy for the FY 2014/15 population.</p>
answering member constituency Ipswich more like this
answering member printed Ben Gummer more like this
question first answered
less than 2015-11-03T17:47:39.64Zmore like thismore than 2015-11-03T17:47:39.64Z
answering member
3988
label Biography information for Ben Gummer more like this
attachment
1
file name Copy of MRSA_annual_data_FY_2014_2015.xls more like this
title MRSA data 2014-15 more like this
tabling member
1447
label Biography information for Andrew Rosindell more like this
423895
registered interest false more like this
date less than 2015-10-26more like thismore than 2015-10-26
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Obesity more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to tackle obesity. more like this
tabling member constituency Romford more like this
tabling member printed
Andrew Rosindell remove filter
uin 13413 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-11-03more like thismore than 2015-11-03
answer text <p>We will put forward our plans to tackle obesity in our childhood obesity strategy in the new year.</p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-11-03T16:22:37.977Zmore like thismore than 2015-11-03T16:22:37.977Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1447
label Biography information for Andrew Rosindell more like this
421117
registered interest false more like this
date less than 2015-10-13more like thismore than 2015-10-13
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Human Papillomavirus: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what assessment his Department has made of the implications for its policy of the potential link between the HPV Vaccine and Postural Orthostatic Tachycardia Syndrome; and what assessment he has made of the effect of such a link on the progress of the Government's HPV vaccination programme. more like this
tabling member constituency Romford more like this
tabling member printed
Andrew Rosindell remove filter
uin 11694 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-10-21more like thismore than 2015-10-21
answer text <p>The human papillomavirus (HPV) sub-committee of the Joint Committee on Vaccination and Immunisation (JCVI), which advises the Department on immunisation matters, considered the safety of HPV vaccine when it met in June 2015. The sub-committee reviewed safety information provided by the Medicines and Healthcare products Regulatory Agency (MHRA), as well as reports in the media and literature investigating temporal associations of the HPV vaccine to a range of overlapping syndromes including postural orthostatic tachycardia syndrome (POTS). The HPV sub-committee agreed that no available evidence supports a causative link between HPV vaccination and POTS or other overlapping syndromes. It strongly supported the continued use of the HPV vaccine to prevent infection with HPV and to protect adolescent girls from cervical and other HPV associated cancers. This position was agreed by the JCVI, which concluded it has no concerns about the safety of the HPV vaccine.</p><br /><p>As with all vaccines and medicines, the safety ofHPV vaccines will be kept under continual review.</p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-10-21T16:21:45.583Zmore like thismore than 2015-10-21T16:21:45.583Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1447
label Biography information for Andrew Rosindell more like this
421120
registered interest false more like this
date less than 2015-10-13more like thismore than 2015-10-13
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Barking, Havering and Redbridge University Hospitals NHS Trust: Care UK more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what progress has been made in the arbitration dispute between the Barking, Havering and Redbridge University Trusts and Care UK, over which institution will deliver services from the King George Elective Care Centre, Redbridge, on behalf of the Barking/Dagenham, Havering and Redbridge Clinical Commissioning Groups; and what steps his Department is taking to ensure that both parties receive a prompt decision by the arbitration tribunal. more like this
tabling member constituency Romford more like this
tabling member printed
Andrew Rosindell remove filter
uin 11720 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-10-21more like thismore than 2015-10-21
answer text <p>We understand that Monitor is responding to a complaint made by Care UK about the procurement of elective care services at The North East London NHS Treatment Centre located at King George Hospital, Goodmayes.</p><p>We are advised that the investigation is on-going. Monitor published a statement of issues on 21 August and will publish its findings in due course.</p><p><strong></strong></p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-10-21T14:50:17.097Zmore like thismore than 2015-10-21T14:50:17.097Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1447
label Biography information for Andrew Rosindell more like this
384978
registered interest false more like this
date less than 2015-06-23more like thismore than 2015-06-23
answering body
Department of Health remove filter
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Bladder Cancer: Medical Treatments more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to increase the level of investment in treatment for bladder cancer. more like this
tabling member constituency Romford more like this
tabling member printed
Andrew Rosindell remove filter
uin 3790 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-07-01more like thismore than 2015-07-01
answer text <p>Improving cancer outcomes, including for those with bladder cancer, is a major priority for this Government and we await the recommendation of the independent Cancer Taskforce this summer.</p><p> </p><p> </p><p> </p><p>In commissioning cancer services, NHS England is supported by Clinical Reference Groups (CRGs) which are responsible for developing strategies, pathways and service specifications for each group of cancer types, including a Specialised Urology CRG which covers bladder cancer.</p><p> </p><p> </p><p> </p><p>My colleague, the Parliamentary Under Secretary of State for Life Sciences, has launched an Accelerated Access Review to make recommendations to Government later in the year on speeding up access for National Health Service patients to innovative and cost effective new medicines, diagnostics and medical technologies.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-07-01T15:24:40.61Zmore like thismore than 2015-07-01T15:24:40.61Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1447
label Biography information for Andrew Rosindell more like this